D-Methionine provides excellent protection from cisplatin ototoxicity in the rat

Hearing Research

Volumn 102, Issue 1-2, 1996, Pages 90-98

  Campbell, Kathleen C M ^a   Rybak, Leonard P ^a   Meech, Robert P ^a   Hughes, Larry ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; Methionine; Ototoxicity; Protection

Indexed keywords

CISPLATIN; METHIONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COCHLEA; CONTROLLED STUDY; ELECTRON MICROSCOPY; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT;

ACOUSTIC STIMULATION; ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; AUDITORY THRESHOLD; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HAIR CELLS, OUTER; MALE; METHIONINE; MICROSCOPY, ELECTRON, SCANNING; POISONING; RATS; RATS, WISTAR; STEREOISOMERISM; TISSUE FIXATION; WEIGHT LOSS;

EID: 0030561543     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(96)00152-9     Document Type: Article

References (65)

1. Aamdal, S., Fodstad, O. and Pihl, A. (1987) Some procedures to reduce cis-platinum toxicity reduce antitumour activity. Cancer Treat. Rev. 14, 389-395.
2. Aguilar-Markulis, N.V., Beckley, S., Priore, R. and Mettlin, C. (1981) Auditory toxicity effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients. J. Surg. Oncol. 16, 111-123.
3. Alden, W.W. and Repta, A.J. (1984) Exacerbation of cisplatin-induced nephrotoxicity by methionine. Chem.-Biol. Interact. 48, 121-124.
4. Anderson, M.E., Naganuma, A. and Meister, A. (1990) Protection against cisplatin toxicity by administration of glutathione ester. FASEB J. 4, 3251-3255.
5. Anniko, M. and Sobin, A. (1986) Cisplatin: Evaluation of its ototoxic potential Am. J. Otol. 7, 276-293.
6. Bajorin, D., Bosl, G.J. and Fein, R. (1987) Phase I trial of escalating doses of cisplatin in hypertonic saline. J. Clin. Oncol. 5, 1589-1593.
7. Berry, J.M., Jacobs, C., Sikic, B., Jalsey, J. and Borch, R.F. (1990) Modification of cisplatin toxicity with diethyldithiocarbamate. J. Clin. Oncol. 8, 1585-1590.
8. Berry, J.M., Sikic, B.I., Halsey, J. and Jacobs, C.D. (1989) A phase 1 trial of diethyldithiocarbamate (DDTC) as a modifier of cisplatin (CP) toxicity. Proc. ASCO 266, 69.
9. Blumenreich, M.S., Woodcock, T.M., Jones, M., Richman, S.P., Gentile, P.S., Kubota, T.T. and Allegra, J.C. (1985) High-dose cisplatin in patients with advanced malignancies. Cancer 55, 1118-1122.
10. 3+-pretreatment in the rat in vivo and in vitro. Biochem. Pharmacol. 41, 369-375.
11. Borch, R.F., Dedon, P.C. and Montine, T.J. (1988) Experimental approaches to reducing platinum induced kidney toxicity. In: M.P. Hacker, J.S. Lazo and T.R. Tritton (Eds.), Organ Directed Toxicities of Anticancer Drugs, Martinus Nijhoff, Dordrecht, pp. 190-200.
12. Church, M.W., Kaltenbach, J.A., Blakely, B.W. and Burgio, D.L. (1995) The comparative effects of sodium thiosulfate, diethylcarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear. Res. 86, 195-203.
13. Dedon, P.C. and Borch, R.F. (1984) Diethyldithiocarbamate (DDTC) reversal of cisplatin (DDP) nephrotoxicity. AACR Abstr. 1470, 371.
14. Estrem, S.A., Babin, R.W., Ryu, J.H. and Moore, K.C. (1981) Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngol. Head Neck Surg. 89, 638-745.
15. Fausti, S.A., Schechter, M.A., Rapport, B.Z. and Frey, R.H. (1984) Early detection of cisplatin ototoxicity. Selected case reports. Cancer 53, 224-231.
16. Fillastre, J.P. and Raguenez-Viotte (1989) Cisplatin nephrotoxicity. Toxicol. Lett. 46, 163-175.
17. Fleischman, R.W., Stadnicki, S.W., Ethier, M.F. and Scheappi, U. (1975) Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig. Toxicol. Appl. Pharmacol. 33, 320-332.
18. Forastiere, A.A., Takasugi, B.J., Baker, S.R., Wolf, G.T. and Kudla-Hatch, V. (1987) High-dose cisplatin in advanced head and neck cancer. Cancer Chemother. Pharmacol. 19, 155-158.
19. Gandara, D.R., Perez, E.A., Phillips, W.A., Lawrence, H.J. and DeGregoria, M. (1989) Evaluation of cisplatin dose intensity: current status and future prospects. Anticancer Res. 9, 1121-1128.
20. Griffin, J.P., (1988) Review article: Drug-induced ototoxicity. Br. J. Audiol. 22, 195-210.
21. Hacker, M.P. (1991) Toxicity of platinum-based anticancer drugs. In G. Powis and M.P. Hacker (Eds.), The Toxicity of Anticancer Drugs, Pergamon Press, pp. 82-105.
22. Hanneman, J. and Baumann, K. (1988) Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 51, 119-132.
23. Hoeve, L.J., Mertens zur Borg, I.R.A.M., Rodenburg, M., Brocaar, M.P. and Groen, B.G.S. (1988) Correlations between cis-platinum dosage and toxicity in a guinea pig model. Arch. Otorhinolaryngol. 245, 98-102.
24. Hoffman, R. M. (1985) Altered methionine metabolism and trans-methylation in cancer. Anticancer Res. 5, 1-30.
25. Jones, M.M. and Basinger, M.A. (1989) Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma. Anticancer Res. 9, 1937-1942.
26. Jones, M.M., Basinger, M.A., Mitchell, W.M. and Bradley, C.A. (1986) Inhibition of cis-diamminedichloroplatinum (II)-induced renal toxicity in the rat. Cancer Chemother. Pharmacol. 17, 38-42.
27. Jones, M.M., Basinger, M.A. and Holscher, M.A. (1991a) Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity. Toxicology 68, 227-247.
28. Jones, M.M., Basinger, M.A. and Holscher, M.A. (1991b) Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res. 11, 449-454.
29. Jones, M.M., Basinger, M.A., Field, L. and Holscher, M.A. (1991c) Coadministration of dimethyl sulfoxide reduces cisplatin nephrotoxicity. Anticancer Res. 11, 1939-1942.
30. Jones, M.M., Basinger, M.A. and Holscher, M.A. (1992) Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds. Fund. Appl. Toxicol. 18, 181-188.
31. Kaji, H., Niioka, T., Kojima, Y., Yoshida, Y. and Kawakami, Y. (1987) Urinary 3-methylthiopropionate excretion and the effect of D- or L-methionine ingestion studied in healthy subjects. Res. Commun. Chem. Pathol. Pharmacol. 36, 101-109.
32. Kies, C., Fox, H. and Aprahamian, S. (1975) Comparative value of L-, DL- and D-methionine supplementation of an oat-based diet in humans. J. Nutr. 105, 809-814.
33. Koegel, L. (1985) A contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erthromycin and cisplatinum. Am. J. Otol. 6, 190-199.
34. Komune, S. (1981) Potentiating effects of cisplatin and ethacrynic acid in ototoxicity. Arch. Otolaryngol. 101, 66-74.
35. Kopelman, J., Budnick, A.S., Kramer, M.B., Sessions, R.B. and Wong, G.Y. (1988) Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 98, 858-864.
36. Laurell, G, and Engström, B. (1989) The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear. Res. 38, 27-34.
37. Lempers, E.L.M. and Reedijk, J. (1990) Reversibility of cisplatin-methionine in proteins by diethyldithiocarbamate or thiourea: A study with model adducts. Inorgan. Chem. 29, 217-222.
38. Lippman, A.J., Helson, C., Helson, L. and Krakoff, I.H. (1973) Clinical trials of cis-diamminedichloroplatinum (NSC-119875). Cancer Chemother. Rep. Part 1 57, 191-200.
39. Melamed, A.B., Selim, M.A., Facog, Facs and Schuchman, D. (1985) Cisplatin ototoxicity in gynecologic cancer patients. A preliminary report. Cancer 55, 41-43.
40. Melvik, J.E. and Petterson, E.O. (1987) Reduction of cis-dichlorodiammineplatinum-induced cell inactivation by methionine. Inorgan. Chim. Acta 137, 115-118.
41. 11C- L- and D-methionine in brain tumors. Eur. J. Nucl. Med. 10, 373-376.
42. Meyer, W.H. (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J. Clin. Oncol. 7, 754-760.
43. Moroso, M.J. and Blair, R.L. (1983) A review of cis-platinum ototoxicity. J. Otolaryngol. 12, 365-369.
44. Nakano, S. and Gemba, M. (1989) Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by butathione depletion. Jpn. J. Pharmacol. 50, 87-92.
45. Olin, B., Hebel, S.K., Connell, S.I., Dombek, C.E., Kastrup, E.K. (Eds.) (1991) Drug Facts and Comparisons, J.P. Lippincott, St. Louis, MO, p. 2115.
46. Otto, W.C., Brown, R.D., Gage-White, L. Kupetz, S., Anniko, M., Penny, J.E. and Henley, C.M. (1988) Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hear. Res. 35, 79-86.
47. Ozols, R.F. and Young, R.C. (1985) High-dose cisplatin therapy in ovarian cancer. Semin. Oncol. 12, Suppl. 6, 21-30.
48. Pfeifle, C.E., Howell, S.B., Felthouse, R.D., Woliver, T.B.S. andrews, P.S., Markman, M. and Murphy, M.P. (1985) High-dose cisplatin with sodium thiosulfate protection. J. Clin. Oncol. 3, 237-244.
49. Pollera, C.F., Marolla, P., Nardi, M., Ameglio, F., Cozzo, L. and Bevere, F. (1988) Very high-dose cisplatin-induced ototoxicity: A preliminary report on early and long-term effects. Cancer Chemother. Pharmacol. 21, 61-64.
50. Printen, K.J., Brummel, M.C., Ei Soon Cho, M.S. and Stegink, L.D. (1979) Utilization of D-methionine during total parenteral nutrition in postsurgical patients. Am. J. Clin. Nutr. 32, 1200-1205.
51. Qazi, R., Chang, A.Y.C., Borch, R.F., Montine, T, Dedon, P., Loughner, J. and Bennett, J.M. (1988) Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J. Natl. Cancer Inst. 80, 1486-1492.
52. Ravi, R., Rybak, L.P, and Somani, S.M. (1991) Relationship of pharmacodynamic effects of cisplatin to the glutathione levels in cochlea, inferior colliculus and kidney. Pharmacologist 33, 217.
53. Ravi, R. Somani, S. and Rybak, L. (1995) Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76, 386-394.
54. Rothenberg, M.L., Ostchega, Y., Steinberg, S.M., Young, R.C., Hummel, S. and Ozols, R.F. (1988) High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer. J. Natl. Cancer Inst. 80, 1488-1492.
55. Rybak, L.P., Ravi, R. and Somani, S. (1995) Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fund. Appl. Toxicol. 26, 293-300.
56. Schaefer, S.D., Post, J.D., Close, L.G. and Wright, C.G. (1985) Ototoxicity of low- and moderate-dose cisplatin. Cancer 56, 1934-9.
57. Schweitzer, V.G. (1993) Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents. Laryngoscope 103, 1-52.
58. Stegink, L.D., Bell, E.F., Filer, L.J., Ziegler, E.E., Andersen, D.W. and Seligson, F.H. (1986) Effects of equimolar doses of L-methionine, D-methionine and L-methionine-DL-sulfoxide on plasma and urinary amino acid levels in normal adult humans. J. Nutr. 116, 1185-1192.
59. Stewart, D.J., Verma, S. and Maroun, J.A. (1987) Phase I study of the combination of disulfiram with cisplatin. Am. J. Clin. Oncol. 10, 517-519.
60. Stoter, G., Koopman, A., Vendrik, C.P., Struyvenberg, A., Sleyfer, D.T., Willemse, P.H., Schraffordt, K.H., van Oasterom, A.T., ten Bokkel, Huinink, W.W. and Pinedo, H.M. (1989) Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine and bleomycin. J. Clin. Oncol. 7, 1099-1104.
61. Sugihara, K., Nakano, S. and Gemba, M. (1987a) Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn. J. Pharmacol. 44, 71-76.
62. Sugihara, K., Nakano, S., Koda, M., Tanaka, K., Fukuishi, N. and Gemba, M. (1987b) Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn. J. Pharmacol. 43, 247-252.
63. Tange, R.A., Conijn, EAJG, Van Zeijl LPGM (1982) The cortitoxic effect of cis-platinum in the guinea pig. Arch. Oto-Rhino-Laryngol. 237, 17-26.
64. Tognella, S. (1990) Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treat. Rev. 17, 139-142.
65. Vermorken, J.B., Kapteijn, T.S., Hart, A.A.M. and Pinedo, H.M. (1983) Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur. J. Cancer Clin. Oncol. 19, 53-58.